Novel role of Vav1-Rac1 pathway in actin cytoskeleton regulation in interleukin-13-induced minimal change-like nephropathy

CY Chan, KH Ng, J Chen, J Lu, CGL Lee… - Clinical …, 2016 - portlandpress.com
CY Chan, KH Ng, J Chen, J Lu, CGL Lee, PH Tan, SC Jordan, HY He, HK Yap
Clinical Science, 2016portlandpress.com
Our established interleukin-13 (IL-13) overexpression rat model of minimal change-like
nephropathy provided a platform to study the molecular signalling pathways in T-helper 2
(Th2) cytokine associated minimal change nephrotic syndrome (MCNS). We hypothesized
that IL-13 may act directly on podocytes, causing podocyte foot process effacement and
hence proteinuria in our rat model of minimal change-like nephropathy. The present study
aimed firstly to delineate the glomerular 'gene signature'associated with IL-13-mediated …
Our established interleukin-13 (IL-13) overexpression rat model of minimal change-like nephropathy provided a platform to study the molecular signalling pathways in T-helper 2 (Th2) cytokine associated minimal change nephrotic syndrome (MCNS). We hypothesized that IL-13 may act directly on podocytes, causing podocyte foot process effacement and hence proteinuria in our rat model of minimal change-like nephropathy. The present study aimed firstly to delineate the glomerular ‘gene signature’ associated with IL-13-mediated dysregulation of podocyte-related proteins, and subsequently to investigate the role of the differentially regulated genes (DEGs) in IL-13-mediated podocyte injury. Glomerular transcriptional profile of IL-13-overexpressed rats showed characteristic features of podocyte injury with 87% of podocyte-related genes being significantly down-regulated. Gene expression of Vav1 was shown to be highly up-regulated in the glomeruli of IL-13-overexpressed rats and pathway analysis of the DEGs suggested a possible novel role of Vav1 in podocyte cytoskeleton remodelling. Immunofluorescence examination demonstrated glomerular expression of Vav1 in rats which co-localized with synaptopodin, confirming podocyte expression. However, positive staining for the phosphorylated form of Vav1 (p-Vav1) was only seen in IL-13-overexpressed rats. Moreover, in vitro IL-13 stimulation of human podocytes resulted in phosphorylation of Vav1. This was associated with Rac1 activation and actin cytoskeleton rearrangement, which was abrogated in Vav1 knockdown podocytes. In conclusion, we have demonstrated the role of Vav1-Rac1 pathway characterized by phosphorylation of Vav1, activation of Rac1 and the subsequent actin cytoskeleton rearrangement in IL-13-induced podocyte injury, possibly explaining the podocyte foot process effacement seen in our IL-13 overexpression rat model.
portlandpress.com